Severity: Warning
Message: opendir(/var/lib/php/sessions): Failed to open directory: Permission denied
Filename: drivers/Session_files_driver.php
Line Number: 365
Backtrace:
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
The aim of this review is to highlight the role of semisolid systems as vehicles for nanovesicles and nanoparticles. In general, nanotechnology plays a critical role in facilitating the delivery of therapeutic agents to their active sites, and several nanocarrier systems have been explored for the topical administration of active components. The major disadvantage of the prepared nanosystems is their low viscosity, which reduces the time needed for enough absorption and negatively affects their stability and bioavailability. The role of semisolid systems is to overcome this limitation. In conclusion, this review presents an updated summary of recent advances in the use of semisolids as vehicles for various nanosystems through comprehensive scrutiny of the types of semisolids and their advantages and their role in enhancing the absorption of nanoparticles and nanovesicles.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140447 | PMC |
http://dx.doi.org/10.1080/20415990.2025.2483151 | DOI Listing |
Pharmaceutics
June 2025
Department of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000 Zagreb, Croatia.
Thymol, one of the main compounds of thyme essential oil, has shown promising effects in treating various skin disorders owing to its anti-inflammatory, antimicrobial and antioxidative activities. Due to its limited solubility in water, thymol is commonly used in higher concentrations to achieve a suitable therapeutic effect, which can consequently lead to skin irritation. To overcome these limitations, we incorporated thymol into a vesicular phospholipid gel (VPG), a novel semisolid dermal vehicle consisting of highly concentrated dispersion of phospholipid vesicles (liposomes).
View Article and Find Full Text PDFPolim Med
July 2025
Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Cracow, Poland.
Background: The results of numerous research studies published in recent years suggest that celecoxib (CEL) may be effective in the treatment of various skin disorders. However, to date, no semisolid product containing CEL has been launched.
Objectives: With a focus on the future development of topical products, we aimed to investigate the impact of different semisolid matrices on the in vitro performance of CEL.
Pharmaceuticals (Basel)
May 2025
Department of Pharmacokinetics and Therapeutic Drug Monitoring, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
Diclofenac is a phenylacetic acid derivative classified as a non-selective COX inhibitor. Similar to other NSAIDs, it is characterized by anti-inflammatory, antipyretic, and analgesic effects. Long-term therapy with diclofenac might also lead to severe gastrointestinal, renal, or cardiovascular systems disorders.
View Article and Find Full Text PDFNat Nanotechnol
June 2025
Department of Chemistry, Virginia Tech, Blacksburg, VA, USA.
Polymer electrolytes hold great promise for safe and high-energy batteries comprising solid or semi-solid electrolytes. Multiphase polymer electrolytes, consisting of mobile and rigid phases, exhibit fast ion conduction and desired mechanical properties. However, fundamental challenges exist in understanding and regulating interactions at the electrode|electrolyte interface, especially when using high-potential layered oxide active materials at the positive electrode.
View Article and Find Full Text PDFTher Deliv
June 2025
Department of Chemistry of Natural and Microbial Products, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Giza, Egypt.
The aim of this review is to highlight the role of semisolid systems as vehicles for nanovesicles and nanoparticles. In general, nanotechnology plays a critical role in facilitating the delivery of therapeutic agents to their active sites, and several nanocarrier systems have been explored for the topical administration of active components. The major disadvantage of the prepared nanosystems is their low viscosity, which reduces the time needed for enough absorption and negatively affects their stability and bioavailability.
View Article and Find Full Text PDF